GVK forays into clinical trials with Chinese co

Mumbai: Hyderabad-based GVK Biosciences has tied up with Excel PharmaStudies (Excel), a Chinese clinical research organisation (CRO), to conduct clinical trials in Asia. Under the arrangement, GVK Bio and Excel will help sponsors conduct and manage Phase II-IV of clinical trials, statistical analysis and medical writing.

GVK Bio president Manni Kantipudi said: ���This is a first of a kind alliance between an Indian CRO and a Chinese CRO. The GVK Bio-Excel alliance integrates trial management across India and China and provides sponsors with a single point of contact.���

Any India trial for Excel will be carried out by the GVK Bio clinical research team and will be managed by a core project management team of Excel. Similarly, a GVK Bio China trial will be carried out by the Excel team and managed by GVK Bio project management team. Excel PharmaStudies CEO William Xiong said: ���It is an important step for Excel and our clients to be able to provide full services in both the important countries.���

The alliance provides clinical trial sponsors access to scientific skills, talent pool, flexible resourcing and cost-effectiveness in both India and China. India has sponsor-friendly regulations and strength in phase two and three clinical trials, while China enjoys advantages in phase three trials and phase four studies.